Success Stories: An Indian Research Associate in the Field of Pharmacology Secures O1-A Approval in Just 7 Days with Our Vigilant Assistance in His Petition Preparation & Submission

Client’s Testimonial:

“Thank you so much for sharing this news with me. I am thankful to the whole team. I would love to give a 5-star rating to Chen Immigration Team, again thank you so much for your help!”

On January 10^th, 2022, we received another O1-A (Individuals with Extraordinary Ability or Achievement) approval for a Research Associate 3 in the Field of Pharmacology (Approval Notice).

General Field: Pharmacology

Position at the Time of Case Filing: Research Associate 3

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: January 10^th, 2022

Processing Time: 7 days (Premium Processing Requested)

Case Summary:

A Texas-based research associate from India in the field of pharmacology hired North America Immigration Law Group to help him build a substantial O1A (Individual with Extraordinary Ability or Achievement) case on his behalf to demonstrate how he has spent several years researching the neurodegeneration and brain tumors, addressing our nation’s vital issues in understanding the underlying mechanisms that cause neurodegenerative disease development.

Since we have a successful record of approved I-129 cases, we were certain that our client’s credentials, a consistent impressive record of success, and influence in these areas of study would achieve the O1A visa. We established the same by summarizing a documented record of his authorship in the field of pharmacology which resulted in 10 peer-reviewed scientific articles and 1 book, gathering a total of 451 citations by many other researchers in the field.

In addition, his peer-review experience, where he has conducted 17 reviews to date, shows that he is highly valued as an expert at the top of his field of pharmacology.

To corroborate our client’s petition packet further, we added four recommendation letters signed by his fellow experts. One of them stated the following:

“The quality of his work, as evidenced by the foregoing discussion, is in fact of a level that distinguishes him as a leading expert in the field today. For this reason, I highly recommend that [client] is given every opportunity available to work in the United States for the advancement of pharmacology and the development of effective therapies against neurological disease.”

Viewing his contributions in the field of pharmacology, his research was further supported by funding from the National Institute on Aging and the Michael J. Fox Foundation for Parkinson’s Research. This funding supports projects that work to extend the quality and health of aging individuals nationwide and promote improvements in the lives of people with Parkinson’s Disease. Therefore, his research has major implications for curing neurodegenerative diseases, which primarily affect older populations.

All of these aforementioned facts, when put together, led our client to the O1A approval. We are delighted that we got the opportunity to help him in this process and achieved his O-1A petition approval in just 7 days. Also, we would like to give a special thanks to the premium processing upgrade, a paid option offered by the USCIS that allows petitioners to enjoy expedited adjudication (the case will be processed within 15 days instead of 9-12 months). We congratulate and wish our client all the best in his future endeavors.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.